# K830730: Port-a-Cath Implantable Cath. Sys

- Pathway: 510(k) (Traditional)
- Applicant: Pharmacia, Inc.
- Decided: Jun 30, 1983 after 114 days
- Product code: LJT (Port & Catheter, Implanted, Subcutaneous, Intravascular)
- Device class: 2
- Regulation: 21 CFR 880.5965
- Recalls of this device: 1 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
5 later devices descend from it; 2 cite it directly.
1 of 6 devices in its family (counting itself) has a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. FDA has not posted a summary or statement for it, so its predicates are not known.

## Most influential descendants
- K992697: Port-a-Cath II Trans-Arterial Percutaneous System (1999), 3 descendants of its own
- K061424: Celsite/ Celsite Concept, Access Ports (2006), 1 descendant of its own
- K130576: Celsite Implantable Access Port Systems (2013), 0 descendants of its own
- K033686: Port-a-Cath II Regional Arterial Portal System (2004), 0 descendants of its own
- K994216: Plastic Port Implantable Venous Access System (2000), 0 descendants of its own

## Recalls of this device
- Sep 14, 2015 · Class II · Z-0152-2016: The label on the lid stock of the individual needle packages for a portion of Lot number 46262 contains the incorrect part number, part number description and product image. The part number should be 

Source page: https://510kreport.com/device/K830730
Methodology: https://510kreport.com/methodology